Deletion of macrophage migration inhibitory factor worsens stroke outcome in female mice

Neurobiology of Disease

Volumn 54, Issue , 2013, Pages 421-431

  Turtzo, L Christine ^a,d   Li, Jun ^a   Persky, Rebecca ^a   Benashski, Sharon ^a   Weston, Gillian ^a   Bucala, Richard ^b,c   Venna, Venugopal Reddy ^a   McCullough, Louise D ^a  

^a UNIVERSITY OF CONNECTICUT HEALTH CENTER   (United States)

^b YALE UNIVERSITY   (United States)

^c YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

Estrogen; Focal cerebral ischemia; Inflammation; JAB1; Macrophage migration inhibitory factor; Middle cerebral artery occlusion; MIF; Mouse; Sex differences; Stroke

Indexed keywords

BIOLOGICAL MARKER; CD74 ANTIGEN; ESTROGEN; INTERLEUKIN 1BETA; INTERLEUKIN 6; IONIZED CALCIUM BINDING ADAPTOR MOLECULE 1; JUN ACTIVATION DOMAIN BINDING PROTEIN 1; MACROPHAGE MIGRATION INHIBITION FACTOR; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN INFARCTION SIZE; BRAIN ISCHEMIA; BRAIN MITOCHONDRION; CELL ACTIVATION; CONTROLLED STUDY; ESTROGEN BLOOD LEVEL; FEMALE; GENE DELETION; GENOTYPE; MALE; MICROGLIA; MIDDLE CEREBRAL ARTERY OCCLUSION; MOUSE; NONHUMAN; PRIORITY JOURNAL; SEX DIFFERENCE;

ANIMALS; BLOTTING, WESTERN; DISEASE MODELS, ANIMAL; FEMALE; IMMUNOGENETICS; IMMUNOHISTOCHEMISTRY; IMMUNOPRECIPITATION; INFLAMMATION; MACROPHAGE MIGRATION-INHIBITORY FACTORS; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; SEX CHARACTERISTICS; STROKE;

EID: 84876343600     PISSN: 09699961     EISSN: 1095953X     Source Type: Journal    
DOI: 10.1016/j.nbd.2013.01.016     Document Type: Article

References (64)

1. Ashcroft G.S., et al. Estrogen modulates cutaneous wound healing by downregulating macrophage migration inhibitory factor. J. Clin. Invest. 2003, 111:1309-1318.
2. Bae M.K., et al. Jab1 interacts directly with HIF-1alpha and regulates its stability. J. Biol. Chem. 2002, 277:9-12.
3. Bernhagen J., et al. MIF is a pituitary-derived cytokine that potentiates lethal endotoxaemia. Nature 1993, 365:756-759.
4. Bernhagen J., et al. Macrophage migration inhibitory factor is a neuroendocrine mediator of endotoxaemia. Trends Microbiol. 1994, 2:198-201.
5. Bounkari O.E., Bernhagen J. MIF and autophagy: a novel link beyond "eating". Cell Res. 2012, 22:950-953.
6. Bozza M., et al. Targeted disruption of migration inhibitory factor gene reveals its critical role in sepsis. J. Exp. Med. 1999, 189:341-346.
7. Burger-Kentischer A., et al. Expression of macrophage migration inhibitory factor in different stages of human atherosclerosis. Circulation 2002, 105:1561-1566.
8. Chauchereau A., et al. JAB1 interacts with both the progesterone receptor and SRC-1. J. Biol. Chem. 2000, 275:8540-8548.
9. Chuang Y.C., et al. Macrophage migration inhibitory factor induces autophagy via reactive oxygen species generation. PLoS One 2012, 7:e37613.
10. Daun J.M., Cannon J.G. Macrophage migration inhibitory factor antagonizes hydrocortisone-induced increases in cytosolic IkappaBalpha. Am. J. Physiol. Regul. Integr. Comp. Physiol. 2000, 279:R1043-R1049.
11. Du L., et al. Innate gender-based proclivity in response to cytotoxicity and programmed cell death pathway. J. Biol. Chem. 2004, 279:38563-38570.
12. Gao X.M., et al. Deletion of macrophage migration inhibitory factor protects the heart from severe ischemia-reperfusion injury: a predominant role of anti-inflammation. J. Mol. Cell. Cardiol. 2011, 50:991-999.
13. Garcia-Segura L.M., et al. Neuroprotection by estradiol. Prog. Neurobiol. 2001, 63:29-60.
14. Honma N., et al. Deficiency of the macrophage migration inhibitory factor gene has no significant effect on endotoxaemia. Immunology 2000, 100:84-90.
15. Hsieh Y.C., et al. Downregulation of migration inhibitory factor is critical for estrogen-mediated attenuation of lung tissue damage following trauma-hemorrhage. Am. J. Physiol. Lung Cell. Mol. Physiol. 2007, 292:L1227-L1232.
16. Inacio A.R., et al. Lack of macrophage migration inhibitory factor in mice does not affect hallmarks of the inflammatory/immune response during the first week after stroke. J. Neuroinflammation 2011, 8:75.
17. Inacio A.R., et al. Macrophage migration inhibitory factor promotes cell death and aggravates neurologic deficits after experimental stroke. J. Cereb. Blood Flow Metab. 2011, 31:1093-1106.
18. Inacio A.R., et al. Enriched environment downregulates macrophage migration inhibitory factor and increases parvalbumin in the brain following experimental stroke. Neurobiol. Dis. 2011, 41:270-278.
19. Jin R., et al. Inflammatory mechanisms in ischemic stroke: role of inflammatory cells. J. Leukoc. Biol. 2010, 87:779-789.
20. Kleemann R., et al. Intracellular action of the cytokine MIF to modulate AP-1 activity and the cell cycle through Jab1. Nature 2000, 408:211-216.
21. Koga K., et al. Macrophage migration inhibitory factor provides cardioprotection during ischemia/reperfusion by reducing oxidative stress. Antioxid. Redox Signal. 2011, 14:1191-1202.
22. Kudrin A., Ray D. Cunning factor: macrophage migration inhibitory factor as a redox-regulated target. Immunol. Cell Biol. 2007, 86:232-238.
23. Lang J.T., McCullough L.D. Pathways to ischemic neuronal cell death: are sex differences relevant?. J. Transl. Med. 2008, 6:33.
24. Li X., et al. Chronic behavioral testing after focal ischemia in the mouse: functional recovery and the effects of gender. Exp. Neurol. 2004, 187:94-104.
25. Li H., et al. Sex differences in cell death. Ann. Neurol. 2005, 58:317-321.
26. Liu X., et al. JAB1 accelerates mitochondrial apoptosis by interaction with proapoptotic BclGs. Cell. Signal. 2008, 20:230-240.
27. Luedike P., et al. Cardioprotection through S-nitros(yl)ation of macrophage migration inhibitory factor. Circulation 2012, 125:1880-1889.
28. McCullough L.D., Hurn P.D. Estrogen and ischemic neuroprotection: an integrated view. Trends Endocrinol. Metab. 2003, 14:228-235.
29. McCullough L., et al. Neuroprotective function of the PGE2 EP2 receptor in cerebral ischemia. J. Neurosci. 2004, 24:257-268.
30. McCullough L.D., et al. Ischemic nitric oxide and poly (ADP-ribose) polymerase-1 in cerebral ischemia: male toxicity, female protection. J. Cereb. Blood Flow Metab. 2005, 25:502-512.
31. McCullough L.D., et al. Pharmacological inhibition of AMP-activated protein kinase provides neuroprotection in stroke. J. Biol. Chem. 2005, 280:20493-20502.
32. Miller E.J., et al. Macrophage migration inhibitory factor stimulates AMP-activated protein kinase in the ischaemic heart. Nature 2008, 451:578-582.
33. Morand E.F., Leech M. Macrophage migration inhibitory factor in rheumatoid arthritis. Front. Biosci. 2005, 10:12-22.
34. Morand E.F., et al. MIF: a new cytokine link between rheumatoid arthritis and atherosclerosis. Nat. Rev. Drug Discov. 2006, 5:399-410.
35. Muller I.I., et al. Macrophage migration inhibitory factor is enhanced in acute coronary syndromes and is associated with the inflammatory response. PLoS One 2012, 7:e38376.
36. Nishio Y., et al. Deletion of macrophage migration inhibitory factor attenuates neuronal death and promotes functional recovery after compression-induced spinal cord injury in mice. Acta Neuropathol. 2009, 117:321-328.
37. Oda S., et al. Macrophage migration inhibitory factor activates hypoxia-inducible factor in a p53-dependent manner. PLoS One 2008, 3:e2215.
38. Onodera S., et al. A novel DNA vaccine targeting macrophage migration inhibitory factor protects joints from inflammation and destruction in murine models of arthritis. Arthritis Rheum. 2007, 56:521-530.
39. Onodera S., et al. Active immunization against macrophage migration inhibitory factor using a novel DNA vaccine prevents ovariectomy-induced bone loss in mice. Vaccine 2007, 26:829-836.
40. Oshima S., et al. Macrophage migration inhibitory factor-deficient mice are resistant to ovariectomy-induced bone loss. FEBS Lett. 2006, 580:1251-1256.
41. Pan J.H., et al. Macrophage migration inhibitory factor deficiency impairs atherosclerosis in low-density lipoprotein receptor-deficient mice. Circulation 2004, 109:3149-3153.
42. Qi D., et al. Cardiac macrophage migration inhibitory factor inhibits JNK pathway activation and injury during ischemia/reperfusion. J. Clin. Invest. 2009, 119:3807-3816.
43. Rasband M.N., et al. Dependence of nodal sodium channel clustering on paranodal axoglial contact in the developing CNS. J. Neurosci. 1999, 19:7516-7528.
44. Rendon B.E., et al. Mechanisms of macrophage migration inhibitory factor (MIF)-dependent tumor microenvironmental adaptation. Exp. Mol. Pathol. 2009, 86:180-185.
45. Renner P., et al. Macrophage migration inhibitory factor: gene polymorphisms and susceptibility to inflammatory diseases. Clin. Infect. Dis. 2005, 41(Suppl. 7):S513-S519.
46. Ritzel R.M., et al. Sex, stroke, and inflammation: the potential for estrogen-mediated immunoprotection in stroke. Horm. Behav. 2012.
47. Roger T., et al. MIF regulates innate immune responses through modulation of Toll-like receptor 4. Nature 2001, 414:920-924.
48. Roger V.L., et al. Heart disease and stroke statistics-2012 update: a report from the American Heart Association. Circulation 2012, 125:e2-e220.
49. Savaskan N.E., et al. Brain miffed by macrophage migration inhibitory factor. Int. J. Cell Biol. 2012, 2012:139573.
50. Sawada M., et al. Estrogen receptor antagonist ICI182,780 exacerbates ischemic injury in female mouse. J. Cereb. Blood Flow Metab. 2000, 20:112-118.
51. Schilling M., et al. Microglial activation precedes and predominates over macrophage infiltration in transient focal cerebral ischemia: a study in green fluorescent protein transgenic bone marrow chimeric mice. Exp. Neurol. 2003, 183:25-33.
52. Stein D.G. Brain damage, sex hormones and recovery: a new role for progesterone and estrogen?. Trends Neurosci. 2001, 24:386-391.
53. Stoppe C., et al. Blood levels of macrophage migration inhibitory factor after successful resuscitation from cardiac arrest. PLoS One 2012, 7:e33512.
54. Stoppe C., et al. High postoperative blood levels of macrophage migration inhibitory factor are associated with less organ dysfunction in patients after cardiac surgery. Mol. Med. 2012, 18:843-850.
55. Taylor J.A., et al. Null mutation in macrophage migration inhibitory factor prevents muscle cell loss and fibrosis in partial bladder outlet obstruction. Am. J. Physiol. Renal Physiol. 2006, 291:F1343-F1353.
56. Taylor J.A., et al. Null mutation for macrophage migration inhibitory factor (MIF) is associated with less aggressive bladder cancer in mice. BMC Cancer 2007, 7:135.
57. Turtzo L.C., McCullough L.D. Sex differences in stroke. Cerebrovasc. Dis. 2008, 26:462-474.
58. Turtzo L.C., McCullough L.D. Sex-specific responses to stroke. Future Neurol. 2010, 5:47-59.
59. Viscoli C.M., et al. A clinical trial of estrogen-replacement therapy after ischemic stroke. N. Engl. J. Med. 2001, 345:1243-1249.
60. Wang L., et al. Upregulation of macrophage migration inhibitory factor gene expression in stroke. Stroke 2009, 40:973-976.
61. Wassertheil-Smoller S., et al. Effect of estrogen plus progestin on stroke in postmenopausal women: the Women's Health Initiative: a randomized trial. JAMA 2003, 289:2673-2684.
62. Wu M.Y., et al. Steroid receptor coactivator 3 regulates autophagy in breast cancer cells through macrophage migration inhibitory factor. Cell Res. 2012, 22:1003-1021.
63. Zhang L., et al. Sex-related differences in neuronal cell survival and signaling in rats. Neurosci. Lett. 2003, 337:65-68.
64. Zhu C., et al. Different apoptotic mechanisms are activated in male and female brains after neonatal hypoxia-ischaemia. J. Neurochem. 2006, 96:1016-1027.